Article info
Section 4: Clinical pharmacy services
4CPS-271 Evaluation of the efficacy of anti-PD-L1 immunotherapy in non-microcritical lung cancer in clinical practice
Citation
4CPS-271 Evaluation of the efficacy of anti-PD-L1 immunotherapy in non-microcritical lung cancer in clinical practice
Publication history
- First published March 14, 2021.
Online issue publication
March 15, 2021
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.